Literature DB >> 9704612

The diagnostic usefulness of bone marrow cultures in patients with fever of unknown origin.

E E Volk1, M L Miller, B A Kirkley, J A Washington.   

Abstract

Bone marrow cultures (BMCs) and blood cultures (BCs) are frequently obtained in the evaluation of fever of unknown origin (FUO). However, the low yield of clinically significant isolates leads to questions about their cost-effectiveness. We retrospectively compared BMC with BC and studied the usefulness of bone marrow trephine biopsy (BMTB) histopathology in detecting infection in an unselected population of 61 patients with FUO, among whom 215 BMCs had been performed. For patients who had undergone BMTB, the histopathology was evaluated for granulomas and microorganisms. Only 1 BMC had a clinically significant isolate, Mycobacterium avium complex (MAC), which was also identified by BC. Rhodotorula rubra was found in the BMC of another patient and classified as a contaminant. Both patients had HIV infection. No growth occurred in BCs for the other 59 patients. Culture results for all 26 BMTB specimens were negative; 4 contained nonnecrotizing granulomas, including the case with MAC. BMCs are probably not justified for routine initial evaluation of FUO, but may be valuable after culture results for blood and easily obtainable tissues have been negative. Bone marrow histopathology and special stains for microorganisms in the absence of granulomas were noncontributory.

Entities:  

Mesh:

Year:  1998        PMID: 9704612     DOI: 10.1093/ajcp/110.2.150

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Futility of Performing Bone Marrow Cultures in Pyrexia of Unknown Origin.

Authors:  Anupama Arya; Rahul Naithani
Journal:  Indian J Hematol Blood Transfus       Date:  2016-07-19       Impact factor: 0.900

2.  Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin.

Authors:  Sharon Ben-Baruch; Jonathan Canaani; Rony Braunstein; Chava Perry; Jonathan Ben-Ezra; Aaron Polliack; Elizabeth Naparstek; Yair Herishanu
Journal:  Mayo Clin Proc       Date:  2012-01-09       Impact factor: 7.616

3.  Evaluation of the clinical impact of bone marrow cultures in current medical practice.

Authors:  Gal Sharvit; Daniel Schwartz; Gabriel Heering; Alexander Shulman; Abraham Avigdor; Galia Rahav; Amos Toren; Arnon Nagler; Jonathan Canaani
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

4.  A "bone marrow score" for predicting hematological disease in immunocompetent patients with fevers of unknown origin.

Authors:  Hao-Yuan Wang; Ching-Fen Yang; Tzeon-Jye Chiou; Sheng-Hsiang Yang; Jyh-Pyng Gau; Yuan-Bin Yu; Chun-Yu Liu; Jin-Hwang Liu; Po-Min Chen; Hui-Chi Hsu; Chang-Phone Fung; Cheng-Hwai Tzeng; Liang-Tsai Hsiao
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.